James R Tribble

10PUBLICATIONS
16CO-AUTHORS
Vision scienceOptical technologyMolecular and organic electronicsNanophotonicsOphthalmology and optometry not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 14, 2025
Identifying potential key metabolic pathways and biomarkers in glaucoma: a systematic review and meta-analysis.

Navid Golpour, Rune L Brautaset, Flora Hui

|Nov 22, 2024
Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma.

|Sep 17, 2024
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production.

James R Tribble, Melissa Jöe, Carmine Varricchio

|Jul 24, 2024
NMNAT2 is a druggable target to drive neuronal NAD production.

James R Tribble, Melissa Jöe, Carmine Varricchio

|Mar 01, 2024
Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume.

Amin Otmani, Gauti Jóhannesson, Rune Brautaset

|Jan 21, 2023
NAD salvage pathway machinery expression in normal and glaucomatous retina and optic nerve.

James R Tribble, Anna Hagström, Kenza Jusseaume

Pageof 2

Frequent Collaborators

9 joint publications

Pete A Williams

3 joint publications

Raymond Ching-Bong Wong

2 joint publications

Andrea Brancale

2 joint publications

Craig E Wheelock